1999
DOI: 10.1038/sj.onc.1203123
|View full text |Cite
|
Sign up to set email alerts
|

CSF-1 activates MAPK-dependent and p53-independent pathways to induce growth arrest of hormone-dependent human breast cancer cells

Abstract: The CSF-1 receptor (CSF-1R) is expressed in 450% of human breast cancers. To investigate the consequence of CSF-1R expression, hormone-dependent human breast cancer cell lines, MCF-7 and T-47D, were transfected with CSF-1R. Unexpectedly, CSF-1 substantially inhibited estradiol (E 2 ) and insulin-dependent proliferation of MCF-7 transfectants (MCF-7fms) and prevented cyclin E/cdk2 and cyclin A/cdk2 activation, consistent with a G 1 arrest. In contrast, CSF-1 increased DNA synthesis in T-47D transfectants (T-47D… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
17
1

Year Published

2000
2000
2014
2014

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 20 publications
(20 citation statements)
references
References 65 publications
(59 reference statements)
2
17
1
Order By: Relevance
“…Waf1 (49). Such disparate behavior illustrates the now well-documented concept that cellular context plays an important role in determining outcome of ERK activation (reviewed in reference 53).…”
mentioning
confidence: 94%
“…Waf1 (49). Such disparate behavior illustrates the now well-documented concept that cellular context plays an important role in determining outcome of ERK activation (reviewed in reference 53).…”
mentioning
confidence: 94%
“…11h). Although persistent CSF-1-induced Erk activity can lead to cell cycle arrest (30), inhibition of Erk activity resulted in diminished proliferation in both WT and Gab2 Ϫ/Ϫ BMMs (Fig. 11i).…”
Section: Phospho-flow Analysis Reveals Defective Akt Erk and S6 Sigmentioning
confidence: 99%
“…The estrogenic effects of isoflavones include binding to the estrogen receptor (ER) or the type II estradiol (E2)-binding site [18,19], promotion of proliferation of reproductive organs in animals [39], induction of pS2 protein expression [29] and stimulation of growth in estrogen-dependent human breast cancer cells [12,13,37]. Suggested antiestrogenic effects include competition with E2 for binding to the ER [34], reduction of estrogen synthesis via the inhibition of aromatase activity [1], down-regulation of E2-induced expression of ER and the pS2 protein in MCF-7 cells [14,38], and inhibition of E2-induced growth in breast cancer cells [12,13,25].…”
Section: Introductionmentioning
confidence: 99%